Several studies have revealed that the abnormal expression of GABPA was related to poor survival in various cancers, including leukemia, hepatocellular carcinoma, thyroid cancer, bladder cancer, and prostate cancer [6, 17–22]. This evidence concerns the gene GABPA and urinary bladder carcinoma.